等待开盘 11-19 09:30:00 美东时间
+0.032
+9.66%
11月19日,Neumora Therapeutics(NMRA)收涨9.66%,报0.37美元,成交额53.41万美元,市值6921.28万美元。 行情数据...
今天 08:14
Neumora Therapeutics (NASDAQ:NMRA) reported quarterly losses of $(0.18) per share which beat the analyst consensus estimate of $(0.20) by 10 percent. This is a 48.57 percent increase over losses of $(0.35) per share from the same period last year.
11-16 21:04
Neumora Therapeutics submitted an IND for NMRA-215 (NLRP3 inhibitor) for obesity and cardiometabolic disease. NMRA-511 (V1aR antagonist) showed dose-proportional exposure in a MAD expansion cohort, suggesting potential to build on Phase 1b efficacy in AD agitation. The company reported a cash position of $85.7 million as of September 30, 2026, with R&D expenses at $22.6 million and a net loss of $34.4 million for the quarter. NMRA-215 demonstrate...
11-16 13:00
11月13日,Neumora Therapeutics(NMRA)收跌8.46%,报0.43美元,成交额39.23万美元,市值8135.91万美元。 行情数据...
11-13 08:47
11月6日,Neumora Therapeutics(NMRA)收跌13.96%,报0.49美元,成交额83.99万美元,市值9155.6万美元。 行情数据 ...
11-06 08:05
11月3日,Neumora Therapeutics(NMRA)收涨34.99%,报0.5美元,成交额275.85万美元,市值9314.05万美元。 行情数据...
11-03 08:03
10月24日,Neumora Therapeutics(NMRA)收跌6.48%,报0.38美元,成交额31.37万美元,市值7128.81万美元。 行情数据...
10-24 07:15
10月20-22日上海黄浦江畔,2026可持续全球领导者大会再度来袭。诺奖、图灵奖得主现场讲述科技未来与趋势,更有“解救”焦虑、内卷时代的网红教授——麦克法兰与...
10-17 07:11